DIAGNOSIS AND THERAPY OF BIGEMINY AND FREQUENT PREMATURE CONTRACTIONS

• US 20120101541A1
• Filed: 10/26/2010
• Published: 04/26/2012
• Est. Priority Date: 10/26/2010
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Corbucci, Giorgio, Beckers, Frank, Rieger, Guido H.
• Granted Patent: US 8,437,851 B2
• Time in Patent Office: Days
• US Class Current: 607/17
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/02405 Determining heart rate variability
• CPC Class Codes: A61B 5/0245 by using sensing means generating electric signals, i.e. ECG signals
• CPC Class Codes: A61B 5/364 Detecting abnormal ECG interval, e.g. extrasystoles, ectopic heartbeats
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3624 occurring in the atrium, i.e. atrial tachycardia
• CPC Class Codes: A61N 1/3702 Physiological parameters A61N1/365 takes precedence; evoked response A61N1/371
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/395 for treating atrial fibrillation
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

The disclosure describes techniques for diagnosing premature contractions of a patient'"'"'s heart. This system may differentiate premature atrial contractions (PACs) and premature ventricular contractions (PVCs) from atrial fibrillation by identifying changes in R-wave intervals, i.e., R-R intervals, on a Lorenz plot, measuring a coupling interval between R-waves, and analyzing a morphology of the premature contractions, e.g., the QRS complex. These techniques may also identify when severe premature contractions, or bigeminy, are present. In response to the type of premature contractions detected, the system may alert a user of the premature contractions and/or deliver cardiac pacing at an increased pacing rate to eliminate the abnormal intrinsic contractions. The system may also adjust the pacing rate and pacing rate duration for persistent premature contractions.

Claims

1. A method comprising:

monitoring a heart of a patient for cardiac cycle lengths;

determining a degree of variability of the cardiac cycle lengths; and

automatically differentiating, by a processor, premature cardiac events from atrial fibrillation based on the determined degree of variability.

2. The method of claim 1, wherein:

the degree of variability is determined by changes in cardiac cycle lengths plotted on a Lorenz plot;

cardiac cycle length changes due to premature cardiac events are clustered in two locations opposite each other and within opposing quadrants of the Lorenz plot; and

cardiac cycle length changes due to atrial fibrillation are scattered throughout the Lorenz plot.

3. The method of claim 1, further comprising identifying the premature cardiac events as either premature atrial contractions or premature ventricular contractions.

4. The method of claim 3, further comprising:

analyzing a morphology of the premature cardiac events to identify similarity of R-wave amplitude, polarity, and duration;

measuring a coupling interval between R-waves; and

identifying the premature cardiac events as premature ventricular contractions when the analysis includes R-waves of differing amplitude, direction, and duration and the measurement indicates a constant coupling interval.

5. The method of claim 1, wherein monitoring the heart comprises detecting a cardio-electrogram with a single lead of a single chamber cardiac therapy device.

6. The method of claim 1, further comprising presenting an alert to a user that at least one of identifies the detected premature cardiac events as premature atrial contractions or premature ventricular contractions, or identifies whether the patient is at risk of heart failure or stroke.

7. The method of claim 1, further comprising delivering cardiac pacing therapy at an increased pacing rate upon detecting premature cardiac events.

8. The method of claim 7, further comprising incrementally increasing the pacing rate until the cardiac pacing therapy eliminates the premature cardiac events.

9. The method of claim 7, further comprising incrementally increasing a pacing duration of the increased pacing rate until the cardiac pacing therapy eliminates the premature cardiac events.

10. The method of claim 1, wherein the cardiac events comprise R-waves.

11. A system comprising:

an implantable medical device configured to monitor a heart of a patient for cardiac cycle lengths; and

a premature detection module configured to determine a degree of variability of the cardiac cycle lengths and automatically differentiate premature cardiac events from atrial fibrillation based upon the determined degree of variability.

12. The system of claim 11, wherein:

the premature detection module is configured to generate a Lorenz plot of changes in cardiac cycle lengths to determine the degree of variability;

cardiac cycle length changes due to premature cardiac events are clustered in two locations opposite each other and within opposing quadrants of the Lorenz plot; and

cardiac cycle length changes due to atrial fibrillation are scattered throughout the Lorenz plot.

13. The system of claim 11, wherein the premature detection module is configured to identify the premature cardiac events as either premature atrial contractions or premature ventricular contractions.

14. The system of claim 13, wherein the processor is configured to:

analyze a morphology of the premature cardiac events to identify similarity of R-wave amplitude, polarity, and duration;

measure a coupling interval between R-waves; and

identify the premature cardiac events as premature ventricular contractions when the analysis includes R-waves of differing amplitude, direction, and duration and the measurement indicates a constant coupling interval.

15. The system of claim 11, wherein:

the implantable medical device is a single chamber cardiac therapy device; and

the premature detection module is configured to analyze a cardio-electrogram to monitor the heart.

16. The system of claim 11, further comprising:

a telemetry module within the implantable medical device and configured to transmit an alert that at least one of identifies the detected premature cardiac events as premature atrial contractions or premature ventricular contractions and identify whether the patient is at risk of heart failure or stroke; and

an external programmer configured to present the alert to a user.

17. The system of claim 11, further comprising:

a signal generator configured to generate a cardiac pacing therapy at an increased pacing rate upon detecting premature cardiac events; and

one or more electrodes coupled to the signal generator and configured to at least partially deliver the cardiac pacing therapy, and wherein the premature detection module is configured to set the increased pacing rate above a base pacing rate upon detecting premature cardiac events.

18. The system of claim 17, further comprising a processor configured to at least one of incrementally increase the pacing rate and incrementally increase the pacing duration of the increased pacing rate until the cardiac pacing therapy eliminates the premature contractions.

19. The system of claim 11, wherein the cardiac events comprise R-waves.

20. A system comprising:

means for monitoring a heart of a patient for cardiac cycle lengths;

means for determining a degree of variability of the cardiac cycle lengths; and

means for automatically differentiating premature cardiac events from atrial fibrillation based upon the determined degree of variability.

21. The system of claim 20, further comprising means for identifying the premature cardiac events as either premature atrial contractions or premature ventricular contractions.

22. The system of claim 20, further comprising means for delivering cardiac pacing therapy at an increased pacing rate upon detecting premature cardiac events.